1. Empagliflozin treatment does not affect the hypertensive response to Ang II administration to rats but decreases oxidative stress in the arterial wall, and endothelial and cardiac dysfunction. (25th November 2020) Authors: Bruckert, C; Remila, L; Matsushita, K; Auger, C; Houngue, U; Chaker, A; Park, S; Algara-Suarez, P; Belcastro, E; Jesel, L; Ohlmann, P; Morel, O; Schini-Kerth, V Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Protective effects of dapagliflozin on vascular remodeling in the carotid artery following balloon injury – potential role of angiotensin and purinergic signaling. (14th October 2021) Authors: Matsushita, K; Sato, C; Bruckert, C; Gong, D; Hmadeh, S; Fakih, W; Remila, L; Auger, C; Jesel, L; Ohlmann, P; Kauffenstein, G; Schini-Kerth, V; Morel, O Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Sodium-glucose co-transporter 1 and 2 expression in the mammary artery of patients with bypass surgery: role of the pro-inflammatory response and contribution to oxidative stress. (14th October 2021) Authors: Park, S H; Amissi, S; Algara-Suarez, P; Gong, D S; Mroueh, A; Belcastro, E; Matsushita, K; Bruckert, C; Chaker, A B; Jesel, L; Ohlmann, P; Morel, O; Mazzucotelli, J P; Schini-Kerth, V B Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗